Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

13:26 ET Satsuma Pharmaceuticals Announces First Patient Dosed in EMERGE™, a Phase 3 Efficacy Trial of STS101 for the Acute Treatment of Migraine

Satsuma Pharmaceuticals, Inc. ("Satsuma" or "the Company"), a clinical-stage biopharmaceutical company, today announced dosing of the first patient...


13:13 ET Medicare Issues Positive Draft Local Coverage Determination for Natera's Signatera™ MRD Test in Colorectal Cancer

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that the Palmetto MolDX program has proposed a local coverage...


12:17 ET The ACGME Releases 'CLER National Report of Findings 2019: Initial Visits to Sponsoring Institutions With 2 or Fewer Core Residency Programs'

The ACGME today released the CLER National Report of Findings 2019: Initial Visits to Sponsoring Institutions With 2 or Fewer Core Residency Programs....


10:30 ET Centinel Spine® Announces First Use of the Expanded prodisc® C Family of Devices in US Clinical Study

Centinel Spine, LLC, the largest privately-held spine company focused on anterior column reconstruction, today announced that the first implantation...


09:16 ET Panorama NIPT Achieves 2 Million Test Milestone

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that it has now processed more than two million Panorama®...


09:03 ET Snap Bio's Lead Candidate Overcomes Resistance of Approved Drugs for Liver Cancer

Snap Bio, Inc., a preclinical oncology company, today announced that its lead drug candidate, SNP-162, has been found to effectively overcome...


09:00 ET Amgen And Allergan Announce Positive Top-Line Results From Comparative Clinical Study Of ABP 798, Biosimilar Candidate To Rituxan® (Rituximab)

Amgen (NASDAQ:AMGN) and Allergan plc. (NYSE:AGN) today announced positive top-line results from a comparative clinical study evaluating the efficacy...


08:30 ET Seqirus to Present Data on Pandemic and Seasonal Influenza Vaccines at OPTIONS X Conference

Seqirus, a global leader in influenza prevention, today announced it will feature data in 3 presentations and 24 posters on the company's adjuvant...


08:00 ET Chinook Therapeutics Raises $65 Million Series A Financing to Advance Precision Medicines for Kidney Diseases

Chinook Therapeutics, Inc. today announced a $65 million Series A financing to discover and develop precision medicines for kidney diseases. Founding ...


Aug 21, 2019, 17:00 ET Updated Clinical Results and New Translational Research Data for Daiichi Sankyo's ADCs U3-1402 and DS-1062 to be Presented at the 2019 World Conference on Lung Cancer

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that updated results and new translational research data from two phase 1 ...


Aug 21, 2019, 13:02 ET Criticisms of Recent JAMA Fluoride/IQ Study Are Unfounded

A newly published carefully-researched and meticulously peer-reviewed US government-funded study published in JAMA Pediatrics reports maternal...


Aug 21, 2019, 10:23 ET Viracor Eurofins Collaborates with Northwestern University Comprehensive Transplant Center on Specialized Kidney Transplant Diagnostic

Viracor Eurofins, a leader in transplant testing, announced its research collaboration with the Northwestern University Comprehensive Transplant...


Aug 21, 2019, 07:30 ET Froedtert & the Medical College of Wisconsin Cancer Network is First in the World to Treat Cancer Patient Using the Accuray Radixact® System with Synchrony® Motion Tracking and Correction Technology

Accuray Incorporated (NASDAQ: ARAY) announced today that physicians at the Froedtert & the Medical College of Wisconsin ("MCW") Clinical Cancer...


Aug 21, 2019, 03:17 ET BioInvent Will Conduct Phase l/lla Trial With BI-1206 in Combination With Pembrolizumab (Keytruda) in Solid Tumors

BioInvent International AB (publ) (OMXS: BINV), a company focused on the discovery and development of novel and first-in-class immuno-modulatory...


Aug 20, 2019, 19:17 ET Study Shows Earthing (Grounding) Deepens Meditation Experience

Earthing (grounding) significantly improves the quality of meditation, a popular lifestyle practice that reduces stress and increases wellbeing. An...


Aug 20, 2019, 16:07 ET NKMax America Initiates Phase I Clinical Trial of SNK in Patients with Psoriasis in Mexico

NKMax America, a biotechnology company harnessing the power of the body's immune system through the development of Natural Killer (NK) cell...


Aug 20, 2019, 08:58 ET Group K Diagnostics and Health Network Laboratories Announce the Commencement of a Clinical Trial

Group K Diagnostics (GKD), a biotechnology innovator aiming to transform the diagnostic process, and Health Network Laboratories (HNL), a leader in...


Aug 20, 2019, 08:30 ET Heron Therapeutics Announces Publication of Results from EPOCH 2, a Phase 3 Study of HTX-011 in Patients Undergoing Hernia Repair Surgery

Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing...


Aug 20, 2019, 08:30 ET Q BioMed and Collaborator Chemveda Life Sciences Announce Potential Chemotherapeutic Breakthrough in Liver Cancer

Q BioMed, Inc. (OTCQB: QBIO) and Chemveda Life Sciences are very pleased to announce the successful chemical synthesis of a unique natural compound...


Aug 20, 2019, 08:30 ET Moleculin Announces CTRC Approval of WP1066 Pediatric Brain Tumor Trial

Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug...


Aug 20, 2019, 08:15 ET Aqualung Therapeutics Corporation Receives $225 Thousand Dollar National Institute of Health (NIH) Grant to Establish Biomarker Panel for Patients with Acute Respiratory Distress Syndrome

AQUALUNG THERAPEUTICS CORPORATION receives a $225,000 National Institutes of Health (NIH) (award number R41 HL147769-01) Grant to establish a novel...


Aug 20, 2019, 08:00 ET Soliton Announces Positive Results Demonstrated from Longer RAP Treatment

Soliton, Inc., (NASDAQ:SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from...


Aug 20, 2019, 08:00 ET Eiger Announces FDA Breakthrough Therapy Designation for Peginterferon Lambda for Treatment of Hepatitis Delta Virus Infection

Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), focused on the development and commercialization of targeted therapies for rare and ultra-rare...


Aug 20, 2019, 07:35 ET NCCN Updates Spanish Adaptations of NCCN Guidelines to Enable Better Cancer Prevention, Diagnosis, and Treatment in Spain

The National Comprehensive Cancer Network® (NCCN®) has begun publishing updated versions of cancer care guidelines adapted for Spanish cancer care...


Aug 20, 2019, 07:00 ET Rapid Dose Therapeutics Commences Clinical Research Trial with GI Research Institute and University of British Columbia

BURLINGTON, ON, Aug. 20, 2019 /PRNewswire/ - Rapid Dose Therapeutics Corp. (CSE: DOSE), ("RDT") announced today the commencement of a clinical...